ASO Author Reflections: Fibrinogen and Albumin Score Validated as a Prognostic Factor to Refine the Treatment Strategy for Esophageal Cancer Patients
Ann Surg Oncol
.
2020 Dec;27(Suppl 3):886-887.
doi: 10.1245/s10434-020-09008-1.
Epub 2020 Aug 6.
Authors
Satoru Matsuda
1
,
Hiroya Takeuchi
2
3
,
Hirofumi Kawakubo
1
,
Ryo Takemura
4
,
Yusuke Maeda
1
,
Yuki Hirata
1
5
,
Takuji Kaburagi
6
,
Tomohisa Egawa
5
,
Tomohiko Nishi
6
,
Masaharu Ogura
7
,
Taku Miyasho
8
,
Akihiko Okamura
1
,
Shuhei Mayanagi
1
,
Kazumasa Fukuda
1
,
Rieko Nakamura
1
,
Tomoyuki Irino
1
,
Norihito Wada
1
,
Yuko Kitagawa
1
Affiliations
1
Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
2
Department of Surgery, Keio University School of Medicine, Tokyo, Japan. takeuchi@hama-med.ac.jp.
3
Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan. takeuchi@hama-med.ac.jp.
4
Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
5
Department of Surgery, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan.
6
Department of Surgery, Keiyu Hospital, Yokohama, Japan.
7
Department of Surgery, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
8
School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
PMID:
32761333
DOI:
10.1245/s10434-020-09008-1
No abstract available
MeSH terms
Albumins
Esophageal Neoplasms* / surgery
Esophagectomy
Fibrinogen
Humans
Prognosis
Substances
Albumins
Fibrinogen